| Aeneva Davis, PHARM D | |
|
1725 E Santa Fe St, Gardner, KS 66030-1657 | |
| (913) 884-8411 | |
| Not Available |
| Full Name | Aeneva Davis |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1725 E Santa Fe St, Gardner, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821581331 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-15533 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aeneva Davis, PHARM D 1725 E Santa Fe St, Gardner, KS 66030-1657 Ph: (913) 884-8411 | Aeneva Davis, PHARM D 1725 E Santa Fe St, Gardner, KS 66030-1657 Ph: (913) 884-8411 |
News Archive
New research published in the July issue of the Journal of the American College of Surgeons reveals that African Americans with gastrointestinal stromal tumors (GIST), a rare cancer that begins in the wall of the gastrointestinal tract, now have survival rates equivalent to those of Caucasians. Prior to 2000, African Americans were more likely to develop GIST and less likely to undergo surgical treatment for this type of cancer.
When you park in the office car park, you usually have no problem finding your car again at the end of the day. The next day, you might park a few spots further away. However, in the evening, you find your car, even though the memories of both days are very similar.
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration through the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Atazanavir Sulfate and Ritonavir Tablets, 300 mg/100 mg.
The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The document was published in SCAI's official journal, Catheterization and Cardiovascular Interventions.
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
› Verified 2 days ago
Azkia Mujeeb, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Main St, Gardner, KS 66030 Phone: 913-884-7912 | |
Mr. Sam H. Boyajian, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 E Main St, Gardner, KS 66030 Phone: 913-856-8106 Fax: 913-856-8802 | |
Ms. Christie M. Schroeder, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 E Main St, Gardner, KS 66030 Phone: 913-856-8106 | |
Eugene B. Devillier, B.S. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Main St, Gardner, KS 66030 Phone: 913-884-7912 | |
Dr. Nicole Michele Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Main St, Gardner, KS 66030 Phone: 913-884-7912 | |
Lauren Steiger, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Main St, Gardner, KS 66030 Phone: 913-884-7912 | |
Quoc-nam Tran Do, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Main St, Gardner, KS 66030 Phone: 913-884-7912 |